Publicação científica trimestral do CREMERJ - volume 2 - número 3 - 2023

99 Med. Ciên. e Arte , Rio de Janeiro, v.2, n.3, p.80-100, jul-set 2023 Febre amarela: uma trilha inacabada Terezinha Marta Pereira Pinto Castiñeiras, Luciana Gomes Pedro Brandão, Guilherme Sant'Anna de Lira 44. Casadio L, Nastri AC, Malta FM, Araujo J, Silva JB, Salomao J, et al. Late-Onset Relapsing Hepatitis Associated with Yellow Fever. N Engl J Med 2020;382(21):2059-61. DOI: 10.1056/NEJMc1913036 45. Rezende IM, Pereira LS, Fradico JRB, Pascoal Xavier MA, Alves PA, Campi-Azevedo AC, et al. Late- Relapsing Hepatitis after Yellow Fever. Viruses 2020;12(2):222. DOI: 10.3390/v12020222 46. Denis B, Chirio D, Ponscarme D, Brichler S, Colin de Verdière N, Simon F, et al. Hepatitis Rebound after Infection with Yellow Fever Virus. Emerg Infect Dis 2019;25(6):1248-9. DOI: 10.3201/eid2506.190069 47. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 1981;59(6):895-900. PMID: 6978196 48. World Health Organization. Vaccines and vaccination against yellow fever –WHO Position Paper – June 2013. Weekly Epidemiological Records [Internet]. 2013. Acesso em: 15 dez de 2023];27(5). Disponível em: https://iris.who.int/bitstream/handle/10665/242089/WER8827_269-283.PDF?sequence=1 49. Staples JE, Bocchini JA, Rubin L, Fischer M, Centers for Disease Control and Prevention (CDC). Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015;64(23):647-50. PMID: 26086636 50. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on the Use of Booster Doses of Yellow Fever Vaccine [Internet]. 2018. Acesso em: 15 dez de 2023. Disponível em: https://www. canada.ca/en/public-health/services/publications/diseases-conditions/use-booster-doses-yellow- fever-vaccine.html 51. Mark Gershman, J. Erin Staples. Yellow Fever. Em: CDC Yellow Book 2024: Health Information for International Travel [Internet]. Acesso em: 15 dez de 2023. Disponível em: https://wwwnc.cdc.gov/travel/ yellowbook/2024/infections-diseases/yellow-fever 52. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, et al. Adverse event reports following yellow fever vaccination. Vaccine 2008;26(48):6077-82. DOI: 10.1016/j.vaccine.2008.09.009 53. Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE. Adverse event reports following yellow fever vaccination, 2007-13. J Travel Med 2016;23(5):taw045. DOI: 10.1093/jtm/taw045 54. Eidex RB. History of thymoma and yellow fever vaccination. The Lancet 2004;364(9438):936. DOI: 10.1016/ S0140-6736(04)17017-7 55. Rafferty E, Duclos P, Yactayo S, Schuster M. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review. Vaccine 2013;31(49):5798-805. DOI: 10.1016/j.vaccine.2013.09.030 56. Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005;23(25):3256- 63. DOI: 10.1016/j.vaccine.2005.01.089 57. World Health Organization. Country vaccination requirements andWHO recommendations for vaccination against yellow fever, poliomielytis, and malaria prophylaxis in international travellers [Internet]. 2022. Acesso em: 15 dez de 2023. Disponível em: https://cdn.who.int/media/docs/default-source/travel-and- health/vaccination-requirements-and-who-recommendations-ith-2022-country-list.pdf 58. Kácha O, Kovács BE, McCarthy C, Schuurmans AAT, Dobyns C, Haller E, et al. An Approach to Establishing International Quality Standards for Medical Travel. Frontiers in Public Health [Internet]. 2016;4:29. DOI: 10.3389/fpubh.2016.00029 59. Traiber C, Coelho-Amaral P, Ritter VRF, Winge A. Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk. J Pediatr (Rio J) 2011;87:269-72. DOI: 10.1590/S0021- 75572011000300015 60. Kuhn S, Twele-Montecinos L, MacDonald J, Webster P, Law B. Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk. CMAJ 2011;183(4):E243-5. DOI: 10.1503/cmaj.100619